Status:

RECRUITING

Alternative Prophylaxis in Female Recurrent Urinary Tract Infections

Lead Sponsor:

University Hospital, Basel, Switzerland

Collaborating Sponsors:

IBSA Institut Biochimique SA

Conditions:

Urinary Tract Infections

Urinary Tract Infection (UTI)

Eligibility:

FEMALE

18-70 years

Phase:

PHASE4

Brief Summary

Urological pathogens are effected by rising antimicrobial resistance rates due to the frequent use of antimicrobials for treatment and prophylaxis. Intravesical instillation with hyaluronic acid (HA) ...

Eligibility Criteria

Inclusion

  • Documented history of rUTI, defined as ≥ 3 episodes of (un)complicated UTI documented by urine culture with the isolation of ≥103 cfu/ml of an identified pathogen in the last year with clinical symptoms OR 2 episodes in the last 6 month

Exclusion

  • No informed consent
  • Concomitant UTI (\< 7 days prior to randomisation)
  • Ongoing antimicrobial prophylaxis (e.g. for rUTI or for any other reason like endocarditis, transplanted patients under immunosuppression)
  • Ongoing prophylactic strategy (e.g. immunoactive prophylaxis)
  • Documented underlying urogenital abnormality (e.g. significant post voiding residual volume (\>50 ml), urethral stricture, urethral diverticula, urinary stone, reflux, urinary neoplasia), urological device (e.g. catheter, ureteral stent) or symptomatic pelvic floor disorder (e.g. genital prolapse stage ≥ II)
  • Concomitant disease (i.e. renal insufficiency, diabetes mellitus, corticosteroid use)
  • Urogenital urological or gynecological surgery \< 6 weeks
  • Known allergy to the study medication
  • Use of spermicides or intrauterine device
  • Pregnancy

Key Trial Info

Start Date :

October 27 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2026

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT04095572

Start Date

October 27 2020

End Date

June 1 2026

Last Update

February 19 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Department of Gynecology, University Hospital Basel

Basel, Switzerland, 4031

2

Department of Urology, University Hospital Basel

Basel, Switzerland, 4031